Graham Capital Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,133
Closed -$212K 1334
2025
Q3
$212K Sell
5,133
-35,709
-87% -$1.44M ﹤0.01% 1027
2025
Q2
$1.8M Buy
40,842
+19,822
+94% +$792K 0.03% 394
2025
Q1
$776K Buy
21,020
+1,199
+6% +$42.7K 0.01% 631
2024
Q4
$660K Buy
19,821
+8,883
+81% +$288K 0.01% 643
2024
Q3
$284K Buy
+10,938
New +$272K ﹤0.01% 796
2023
Q3
Sell
-13,725
Closed -$262K 1099
2023
Q2
$262K Buy
+13,725
New +$265K 0.01% 729
2022
Q4
Sell
-18,828
Closed -$295K 1115
2022
Q3
$295K Sell
18,828
-7,855
-29% -$152K 0.01% 910
2022
Q2
$555K Buy
26,683
+14,841
+125% +$306K 0.02% 638
2022
Q1
$268K Sell
11,842
-14
-0.1% -$273 0.01% 763
2021
Q4
$216K Buy
+11,856
New +$227K 0.01% 441
2017
Q1
Sell
-663,180
Closed -$9.89M 105
2016
Q4
$9.89M Sell
663,180
-137,800
-17% -$1.99M 0.4% 30
2016
Q3
$10.2M Buy
+800,980
New +$8.66M 0.33% 42

Other funds holding EXEL

Graham Capital Management's EXEL Position: Q4 2025 in Review

Graham Capital Management sold out of Exelixis (EXEL) in Q4 2025, closing a stake of 5,133 shares — an estimated $212K sold.

Graham Capital Management first reported a position in EXEL in Q3 2016 and held it in 12 quarters. The position peaked at $10.2M in Q3 2016. 685 funds tracked by Wall St. Rank hold EXEL as of Q4 2025.

  • Graham Capital Management reported no remaining Exelixis position as of Q4 2025 after selling out during the quarter.
  • Graham Capital Management sold 5,133 Exelixis shares in Q4 2025, an estimated $212K.
  • Graham Capital Management first reported a position in Exelixis in Q3 2016 and held it in 12 quarters.
  • Graham Capital Management's Exelixis position peaked at $10.2M in Q3 2016.
  • 685 funds tracked by Wall St. Rank held Exelixis as of Q4 2025.

Based on Graham Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.